Search for: "BRISTOL-MYERS SQUIBB" Results 41 - 60 of 867
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Oct 2022, 3:17 am by Cari Rincker
(Nov. 24, 2021), https://ag.ny.gov/press-release/2021/attorney-general-james-secures-51-million-judgment-against-new-york-city-stem. [5] $834 Million Order Entered in Hawai‘i State Court against Bristol-Myers Squibb and Sanofi for Failing to Investigate and Disclose Ineffectiveness of Plavix®, Dept. of the Att’y Gen. [read post]
3 Oct 2022, 5:45 am by Lawrence Solum
Twice in the new era – with Bristol-Myers Squibb (BMS) in 2017 and in the Ford Motor Company (Ford) in 2021 -- the Court has addressed the connection required between the defendant's contact with the forum and harm suffered by the plaintiff. [read post]
28 Aug 2022, 3:53 pm
 Jane LambertPatents Court (Mr Justice Meade) Sandoz Ltd and another v Bristol-Myers Squibb Holdings Ireland (Unlimited) Company  [2022] EWHC 822 (Pat) (7 April 2022)These were two separate actions for the revocation of a European patent (UK)  1 427 415 B1 (“the patent”). [read post]
18 Aug 2022, 12:26 pm by Josh Blackman
[The Court's originalists (Ho, Elrod, and Oldham) disagree on the original meaning of the Due Process of Law.] [read post]
19 Jul 2022, 2:59 pm by Kevin LaCroix
In the following guest post, the authors revisit the question of whether or not securities class action lawsuits against development-stage biotech companies are likelier to survive a motion to dismiss compared to securities suits against other kinds of companies. [read post]
10 Jul 2022, 1:53 pm by Kenneth Jones
  See Post 108 (discussing my initiation to legal in the legal department of Bristol-Myers Squibb). [read post]
20 May 2022, 10:26 am by Holly Brezee
Bristol-Myers Squibb Co., 919 F.3d 699 (2d Cir. 2019). [9] See, e.g. [read post]
4 Apr 2022, 5:29 am by Bob Ambrogi
He has also worked at Booz Allen Hamilton and Bristol Myers-Squibb. [read post]
15 Jan 2022, 8:42 pm by Patent Docs
Elsby of Akin Gump will moderate a panel consisting of Paul Golian of Bristol Myers Squibb and Paula Fritsch of Amgen. [read post]
12 Jan 2022, 11:20 am by Paul Caron
Burke (Florida), Transfers of Zero-Basis Intangibles to a Partnership, 174 Tax Notes Fed. 25 (Jan. 3, 2022): In this report, Burke examines the problem of contributed zero-basis intangibles in light of the IRS’s inadvertent disclosure of a transaction structured by Bristol-Myers Squibb to shift billions of dollars of... [read post]
11 Jan 2022, 11:45 am by luiza
Bristol-Myers Squibb is not the first manufacturer to run into issues with the program. [read post]